All Type of News
Drug industry resists against price slashing policy as government administrative oppression.
A recent government movement of overall 30% price down for insurance drugs ran into a strong resistance by the drug industry, who was claiming it as an administrative oppression of no reasonable economic consideration...
No quality problems of Ferritin additive substances.
The drug industry sharply criticized the recent KFDA administrative measures against the OEM product of Ferritin preparation, saying that the KFDA announcement in public rather created a lot of confusion problems and ...
Local drug production in 2005 predicted to 18,300 billion Won.
Professor Kwon Soon-won, Duksung Women University, recently reported his paper titled "A promotional strategy of Korean health industry", saying that the growth potentiality of drugs showed far higher than cosmetic, m...
KRPMA inaugurated its main operation.
Chairman: Mr. P. Lee of MSD, Standing Chairman: Mr. Shim Han-sup.
The KRPMA took the inaugural meeting at Chosun hotel on March 10 in presence of representatives from about 30 member foreign invested companies and ...
EU Chamber of Commerce urged overall reform pharmaceutical affairs system.
The Pharmaceutical and Intellectual Property Rights Commission of the EU Chamber of Commerce stationed in Seoul officially called for a full opening and overall reform of the pharmaceutical industrial environment, as ...
A new drug for neutrocytopenia on successful development in Korea.
Dong-A pharmaceutical company (President : Yoo Choong-shik) announced recently that Leucosteam, a new drug for treatment of neutrocytopenia, G-CSF, had been successfully developed for the first time in Korea and the 3...
KFDA: exerts to minimize adverse impact of Ferritin impure problems.
The KFDA explained the background of undertaking inspection over the Ferritin preparations since in Sept. last year the district public prosecutor (Suwon) investigated the Ferritin generic products that were made unde...
Listed pharmaceutical companies recorded worst business operation in 1998.
After the IMF economic crisis the business management of 23 leading listed pharmaceutical companies appeared with the lowest sales and extremely deteriorated profits during 1998 fiscal year ending at Dec. 31. (refer t...
Multinational corp. infiltrated to segmented makets with special drugs.
The foreign invested drug companies strove hard for expansion of local pharmaceutical market shares with excellent and special therapeutic product lines such as antidepressants, antiemetics, anti-impotence and anti-he...
1,037 new drugs listed to National Medical Insurance Reimbursement Plan.
Authorization of the National Medical Insurance drug price for new products reserved since Nov. last year due to its transfer from the KPMA to the KFMI (Korea Federation of Medical Insurance) has now resumed for 1,037...
